Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia / Seyed Mohammad Reza Hosseini en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.6 (Junio)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.6 (Junio) . - pp. 846-855 Título : Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia : A randomized, double-blind, placebo-controlled, clinical trial Tipo de documento: texto impreso Autores: Seyed Mohammad Reza Hosseini, Autor ; Mehdi Farokhnia, Autor ; Farzin Rezaei, Autor Fecha de publicación: 2021 Artículo en la página: pp. 846-855 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Desmopresina, DDAVP, Síntomas negativos, Esquizofrenia, Vasopresina Resumen: Considering the role of neurohypophyseal peptides in normal development and function of higher cortical processes along with their proven abnormalities in schizophrenic patients, these pathways have recently attracted greater attention as treatment targets for schizophrenia. Link: ./index.php?lvl=notice_display&id=27000 [artículo] Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia : A randomized, double-blind, placebo-controlled, clinical trial [texto impreso] / Seyed Mohammad Reza Hosseini, Autor ; Mehdi Farokhnia, Autor ; Farzin Rezaei, Autor . - 2021 . - pp. 846-855. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.6 (Junio) . - pp. 846-855 Etiquetas: Desmopresina, DDAVP, Síntomas negativos, Esquizofrenia, Vasopresina Resumen: Considering the role of neurohypophyseal peptides in normal development and function of higher cortical processes along with their proven abnormalities in schizophrenic patients, these pathways have recently attracted greater attention as treatment targets for schizophrenia. Link: ./index.php?lvl=notice_display&id=27000

---

1 (1 - 1 / 1) Por página: 25 50 100 200